VMBIP Newsletter – August 22, 2008
Please scroll past the charts for VMBIP updates.
McKesson Performance Dashboard 
CDC Weekly Performance Metric Scorecard

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-1-08:  97.0 percent
Week Ending 8-8-18;  97.3 percent
Week Ending 8-15-08:  89.2 percent
Weighted Average Last 3 Weeks:  94 percent
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-1-08:  98.8 percent
Week Ending 8-8-18;  98.9 percent
Week Ending 8-15-08:  100 percent
Weighted Average Last 3 Weeks:  99.3 percent
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending 8-1-08:  100 percent
Week Ending 8-8-18;  99.98 percent
Week Ending 8-15-08:  100 percent
Weighted Average Last 3 Weeks:  99.3 percent
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending 8-1-08:  99.09 percent
Week Ending 8-8-18;  99.94 percent
Week Ending 8-15-08:  97.94 percent
Weighted Average Last 3 Weeks:  98.76 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending 8-1-08:  100 percent
Week Ending 8-8-18;  100 percent
Week Ending 8-15-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending 8-1-08:  100 percent
Week Ending 8-8-18;  100 percent
Week Ending 8-15-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending 8-1-08:  100 percent
Week Ending 8-8-18;  93 percent
Week Ending 8-15-08:  100 percent
Weighted Average Last 3 Weeks:  98 percent
Explanation:  8/8: CDC/MCK – Two entries were received and transmitted to the grantee in more than 48 hours due to a delay in creating a new product in the system

A. Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation) - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		
B. Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)	
C1. Percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable/customer not available, or carrier damageC2. Percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address/delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.  Percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.  Percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and  transmits to CDC within 24 (flu) / 48 (other) hrs of delivery by manufacturer	
F.  Percent of grantee replenishment orders McKesson faxes/e-mails receipt of to grantees within 48 hrs of delivery by manufacturer
A. Replace of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an 

Vaccines on allocation HIB and FLU; Vaccines on manufacturer shortage Merck Hep A
Vaccines placed on backorder during the most recent week: DTAPIPHI (420 doses) – orders over allocation; TD (1530 doses) – CDC not ordering vaccine due to short-dated nature of vaccine, orders pending cancellation; TDAP (3395 doses) – delayed arrival of vaccine, inventory has since arrived and orders have been released 

McKesson Performance Dashboard – Shipping Metrics by Distribution Center
CDC Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-1-08:  99.6 percent
Week Ending 8-8-18;  96.4 percent
Week Ending 8-15-08:  84.2 percent
Weighted Average Last 3 Weeks:  92.5 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-1-08:  100 percent
Week Ending 8-8-18;  98.9 percent
Week Ending 8-15-08:  100 percent
Weighted Average Last 3 Weeks:  99.5 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-1-08:  91.2 percent
Week Ending 8-8-18;  99.2 percent
Week Ending 8-15-08:  98.9 percent
Weighted Average Last 3 Weeks:  97.2 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 8-1-08:  96.3 percent
Week Ending 8-8-18;  99.2 percent
Week Ending 8-15-08:  100 percent
Weighted Average Last 3 Weeks: 98.8 percent
Explanation:  none

A. Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		
B. Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)

VMBIP Updates
•	Recently, a box of wasted vaccine was returned to McKesson containing leftover syringes that had been pre-drawn by the clinic staff for intended use at a back-to-school fair.  When the package arrived, some of the syringes were missing caps, causing injury to a McKesson employee.  For everyone's safety, please ensure that your providers clearly understand that pre-drawn syringes must never be returned to McKesson.  Pre-drawn syringes cannot be processed for excise tax credits anyway.  Also, McKesson continues to receive multiple boxes of returned expired/wasted vaccine without the completed expired/wasted vaccine form included inside the box.  In order for McKesson to identify the source and process the returns for excise tax credits, please ensure that your providers submit a copy of the form in the box and submit a copy to you as well. 
•	Akorn adult Td products:  Prior to the start of the new adult contract year in July when placing an order for adult Td, only NDC 14362-0111-01 (15-dose multi-dose vial of the Massachusetts Biologics product) was available.  A 15-dose multi-dose vial of Td is now available through the CDC adult contract in two NDCs, 14362-0111-01 and 17478-0130-10. These two vaccine presentations are identical.  Although both are manufactured by Massachusetts Biologics, Akorn Inc. has approval for the 17478-0130-10 product to be labeled under Akorn's name.  In reviewing provider orders over the last month, it appears that most provider orders for adult Td are for 14362-0111-01.  NDC 17478-0130-10 is available, yet not being ordered in any significant amount.  There is currently a few weeks of inventory remaining of the Td with the Massachusetts Biologics label (14362-0111-01) at each depot.  There are several weeks of inventory of the Akorn label Td (17478-0130-10).  In order to avoid product expiring without being utilized, when placing your order for adult Td, please begin ordering the Akorn multi-dose vials. When NDC 14362-0111-01 is out of stock, we will disable this product in VACMAN.  After the inventory of the 15-dose vials at McKesson are depleted, the multi-dose vial of Td will no longer be available on CDC's adult vaccine contract.  At that time, only the single dose vial (17478-0131-01) will be available on the CDC contract.  Please contact Joy Hill at jkhill@cdc.gov with any questions. 
•	Reminder:  There are two temperature monitors (one warm indicator and one cold indicator) in every box shipped from McKesson to your providers.  Each box contains a hard copy of the attached two flyers describing how to interpret the temperature monitors.  The warm indicator (MonitorMark) gets manually activated during the packout at McKesson; the cold indicator (ColdMark) does not involve manual activation.  If you have any questions around the interpretation of the temperature monitors, please contact Tony Richardson lmr7@cdc.gov 404-639-8374.
As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-08-22-08.rtf